Skip to main content
PLOS One logoLink to PLOS One
. 2025 Aug 19;20(8):e0330125. doi: 10.1371/journal.pone.0330125

Flushing peripheral intravenous catheters: A scoping review

Jiaxin Deng 1,*, Orlaith Hernon 1, Caitríona Duggan 2, Leo R Quinlan 3, Zina Alfahl 4, Peter J Carr 1
Editor: Erik Su5
PMCID: PMC12364367  PMID: 40828796

Abstract

Background

Peripheral intravascular catheters (PIVCs) are indispensable vascular access devices in healthcare, facilitating the administration of intravenous therapies. Despite their vital role, PIVCs are frequently associated with complications such as occlusion, infection, and thrombosis, which contribute to catheter failure. Flushing catheters is one of the most common practices during PIVC maintenance, as it cleans the internal catheter lumen, ensuring patency and reducing the risk of complications. However, inconsistencies in flushing practices such as flushing technique, volume to use, frequency, and methods highlight a lack of consensus in the literature and clinical guidelines.

Methods

Following JBI scoping review methodology, a comprehensive search was conducted across PubMed, Embase, Scopus, CINAHL, and grey literature sources. Studies were included if they focused on PIVC flushing techniques, flushing methods (speed, volume, frequencies, interval), or their impact on catheter-related outcomes. Data were charted using the PAGER (Patterns, Advances, Gaps, Evidence, Research recommendations) framework.

Results

Of the 4539 initial studies retrieved, 39 met the inclusion criteria. Key findings reveal significant variability in flushing practices, with no consensus on optimal technique (continuous, intermittent, or pulsatile), volume (commonly 5–10 mL), or frequency (ranging from every 6 hours to every 24 hours). Pulsatile flushing showed promise in laboratory studies for reducing bacterial colonization and maintaining catheter patency but lacked consistent clinical evidence. Fluid dynamics studies on the flushing process suggested potential endothelial injury from high flushing velocities and the need for standardized practices.

Conclusion

While some studies have investigated PIVC flushing, the existing research remains inconsistent, with a lack of clinical trials and mechanistic evidence on how flushing affects catheter patency, endothelial damage, and complication prevention.

1. Introduction

The peripheral intravenous catheter (PIVC) is a vital invasive device providing intravenous access for administering intravenous medications, solutions, and blood products [1]. PIVC insertion is the most frequently performed invasive procedure in hospitals, with up to 70% of patients requiring one [2]. with an estimated 2 billion PIVCs inserted worldwide annually [3].

Despite their widespread use and necessity, PIVCs are associated with various complications that can be broadly categorized as mechanical or physiological, which can lead to bacterial infectious complications. We suggest mechanical complications include device removal owing to securement failure, catheter dislodgement, and occlusion [4]. Physiological complications include thrombosis, extravasation, and phlebitis [4]. Additionally, interstitial edema may lead to the lifting of dressing edges, affecting catheter securement and increasing the risk of dislodgement and failure [5]. Infectious complications caused by bacteria may be caused locally at the insertion site or systemically if pathogens enter the bloodstream, which can result in thrombophlebitis in the presence of a thrombus [6].

PIVC complications are a burden to patients, clinical staff, and healthcare systems owing to catheter failure and repeat PIVC insertions [2]. The PIVC failure rate can range from 32% to 50%, with one study reporting a failure rate of 36.4%, and an overall incidence rate of 4.42 per 100 catheter days was reported [7,8]. Once the PIVC fails, there are delays in intravenous treatment delivery, patient dissatisfaction, and repeat insertion attempts are challenging as other veins are visibly depleted [9]. It is our contention that flushing the PIVC may contribute to these failure rates.

Drug incompatibilities, including calcium phosphate crystals, or lipid accumulation, can occur when medicines with different pH are infused, which increases the risk of catheter occlusion [10]. Clinical practice guidelines recommend flushing PIVCs as a critical intervention to effectively remove residual medications, maintain catheter patency, and minimize the risk of catheter occlusion [1113]. The Infusion Therapy Standards of Practice recommend using a push-pause technique called pulsatile flushing with a 5 mL to 10 mL syringe of saline to flush PIVCs, ensuring the volume is twice that of the catheter system, both before and after drug administration [1]. This practice plays a role in assessing catheter function, identifying malfunction, and minimizing the risk of occlusion, thrombus, and the potential for catheter-related bloodstream infection [14].

The pulsatile flushing technique delivers the flushing solution in short bursts [15]. This technique induces turbulence within the catheter’s internal lumen, reducing the time required for the deadhesion of solid deposits compared to flushing with a laminar flow [15]. However, the impact of flushing on the vein and blood components is poorly understood. This turbulence can be effective at cleaning solid deposits or biofilm fragments adhered to the internal catheter lumen. Whilst this action intends to clean the PIVC to ensure it is maintained and functional, this intervention often performed by nursing staff can result in physiological consequences as it creates high shear forces that can damage the vein [12]. The resulting stress and inflammation cause endothelial injury and may further encourage catheter failure owing to thrombus formation and interstitial edema [16]. The shear force created by the flush causes turbulence and recirculation at the catheter tip, which forces the platelets and blood cells to collide and may cause the catheter tip to be displaced or piston against the vein wall [17,18]. These potential adverse effects highlight the need for a deep understanding of the flushing practice and its implications, as current evidence remains insufficient to determine the optimal practices for PIVC maintenance [19]. Furthermore, this is a high-priority area of care for nursing as it is the discipline that performs the majority of care and maintenance of PIVCs.

This scoping review aims to systematically map the existing research on PIVC flushing techniques and methods, including the scope, sources of research, and types of evidence [20]. By identifying gaps in the current knowledge and any inconsistencies in practice, this review will provide a rationale for future research. The intention is to improve evidence-based guidelines for PIVC flushing and ultimately improve patient outcomes related to PIVC complications.

2. Scoping review objective and review questions

This scoping review aims to systematically map the existing research on PIVC flushing by assessing existing studies’ scope, methodologies, and outcomes. The intention is to identify gaps in the literature to inform future research directions.

Our review questions include:

  1. What is the body of the literature, including study methodologies, designs, and populations on PIVC flushing? What are the frequency distributions of contributing countries, authors, and clinical environments to the research output on this topic?

  2. What descriptions of flushing techniques (e.g., pulsatile, continuous flushing) and flushing methods (e.g., flushing speed, flushing volume, flushing frequency, and flushing interval) are reported?

  3. Does the literature examine how different catheter flushing methods contribute to catheter-related complications or catheter failure?

3. Method

Our published scoping review protocol adheres to the JBI scoping review methodological guidance [21]. The reporting of this review will follow the reporting guideline, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist [22]. The PAGER (Patterns, Advances, Gaps, Evidence for Practice and Research recommendations) framework will be used to help analyze and present the principle findings from the review [23]

4. Eligibility criteria

4.1. Participants, concept, and content

This study included healthcare professionals (HCP), such as nurses, medical doctors, paramedical HCPs, and vascular access specialists, who perform PIVC insertion, maintenance, and flushing processes, and laboratory professionals who conduct research in this field. The study population includes pediatric and adult patients, as well as animal models where applicable.

All types of peripherally inserted catheters, such as integrated, non-integrated, short, long, extended dwell, and midline catheters used for intravenous therapy (such as chemotherapy, medication administration, and parenteral nutrition), were included in the review. Midline catheters were not considered PIVCs but were included separately in the analysis if applicable. Studies focusing on flushing technique, flushing speed, flushing volume, flushing frequency, and flushing interval were included. Studies were excluded if they focused on the PIVC flushing or locking regimes or solutions (e.g., comparing the outcome difference between heparin and saline).

The context included clinical, laboratory, and simulated settings, including any environment used for training or research purposes, such as manikins, task trainers, and simulation technologies like virtual reality and augmented reality, as long as they relate to catheter flushing practices. In the clinical setting, both inpatient and outpatient settings were included.

4.2. Types of sources

The review included all study methodologies such as qualitative, quantitative, and mixed methods studies. The review included a variety of study designs, including non-experimental, experimental design, retrospective cohort studies, case-control studies, and simulation studies. We included evidence synthesis designs such as systematic reviews with and without meta-analysis and meta-synthesis and scoping reviews. Grey literature, such as conference papers and PhD thesis, were included.

4.3. Information sources

The search strategy was carried out following JBI’s three-phase search strategy [24]. In the first phase, an initial limited search of the flushing of PIVCs was undertaken in PubMed and Embase to identify relevant articles on the topic of interest. The free text keywords and index terms noted from these relevant articles helped further devise our search terms and develop our search strategy. PJ, JD, OH, and CD contributed to developing search terms.

The search was conducted across several databases, including PubMed, Embase, Web of Science, Scopus, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). Clinical trial registries such as the Australian and New Zealand Clinical Trial Registry (ANZCTR), European Union Clinical Trials Register (EUCTR), and ClinicalTrials.gov were also searched. Grey literature was identified by reviewing the first 10 pages of Google and Google Scholar using specific keyword combinations. The search strategy included free-text keywords and MeSH terms related to PIVC and flushing techniques (see Appendix I for detailed search terms and strategy). The search process was finished in October 2024.

4.4. Selection of sources of evidence

All identified literature was imported into Rayyan, and duplicates were removed. Two research team members (JD and OH) were involved in manually screening the literature retrieved from our dedicated search strategy. OH screened 10% of the literature to assess for agreement, and JD continued screening the remaining 90%. The third member (PC) independently used the ASreview tool for study screening, stopping after 100 consecutive non-relevant papers. To ensure a comprehensive review and minimize bias, the manual and ASreview screening results were compared. The research team members discussed discrepancies between the two methods to reach a consensus.

Full texts of potentially relevant studies were reviewed independently by one reviewer (JD). The second and third reviewers (OH and PC) also reviewed 10% of the studies to resolve discrepancies and ensure consistency.

4.5. Data charting process

A standardized data extraction form (Appendix II) was used to extract data, including author(s), year of publication, country of origin, study design, study settings, study subjects, flushing techniques, flushing speed, flushing volume, flushing speed, and flushing frequency, flushing interval, and reported outcomes. One reviewer (JD) conducted the extraction work. We adopted a double-checking system with 10% of the studies, where second and third reviewers (OH and PC) verified the precision and comprehensiveness of the extracted data.

4.6. Analysis, presentation and discussion

Findings are presented using frequency counts and a narrative summary. Where appropriate, data are displayed using figures, tables, and graphs. Our discussion is divided into two sections: the first addresses the four scoping review questions, and the second highlights additional themes and findings identified during the review. The discussion further elaborates on both sections, guided by the PAGER framework [23].

4.7. Protocol amendments

Two amendments were made to our published scoping review protocol. Firstly, we limited the grey literature source to only include the first 10 pages of Google and Google Scholar with specific keyword combinations due to the large body of sources with low quality and irrelevant to the research questions. Secondly, the term PVC (peripheral venous catheter) in the scoping review protocol was replaced with PIVC (peripheral intravenous catheter) to align with standard terminology and better reflect the scope of our research.

5. Results

5.1. Studies inclusion

Our search strategy retrieved 4539 sources and 1418 duplicates were removed, leaving 3121 for title and abstract screening. After two authors’ title and abstract screening, 71 studies were left for full-text screening. We subsequently conducted full-text screening, and then 39 studies met the final extracting requirements, as seen in PRISMA flow diagram (Fig 1) [25]. See Table 1 for a summary of information from the included studies.

Fig 1. PRISMA 2020 flow diagram.

Fig 1

Table 1. For a summary of information from the included 39 studies.

Authors. Research design Research Subject Research setting Flushing technique Flushing speed Flushing volume Flushing frequency Flushing interval Syringe Size Outcome
Mali et al. 2022 [26] Intervention study Inpatients a IF VS Regular flushing NS NS NS NS NS 1, 2
Hosseini et al. 2021 [27] Intervention study Inpatients a PF VS CF PF:1 ml/s
CF:1 ml/s
5 ml PF less than 1s delay Less than 1s NS 2
Keogh et al., 2020 [28] Intervention study Inpatients a PF NS NS NS NS 10 ml pre-filled syringe 3, 4
Kledon et al., 2020 [29] Intervention study Inpatients a NS NS 1 Low frequency, low volume (q24h, 3 mL)
2 Low frequency, high volume (q24h, 10 mL)
3 High frequency, low volume (q6h, 3 mL)
NS NS 3
Keogh, et al, 2016 [30] Intervention study Inpatients a NS NS 1. High volume, high frequency (10 mL q6h)
2. High volume, low frequency (10 mL q24h)
3. Low volume, high frequency (3 mL q6h
4. Low volume, low frequency (3 mL q24h)
NS NS 3, 5
Schreiber et al, 2015 [31] Intervention study Inpatients a positive flush NS 3ml q12h or q24h NS BD PosiFlush XS syringes 2, 4
Parreira et al, 2020 [32] Cross-section study Nurses b CF and PF NS 2-10 ml After PVC insertion, before, between, and after drug delivery NS 2,5,10 ml 6
Keogh, et al,2015 [33] Cross-section study Nurses b NS NS 2-10 mL, with 10 mL most common q12h or q24h NS BD PosiFlush XS syringes 6
Braga et al., 2018 [34] Cross-section study Inpatients and
Nurses
c NS
(manual flushing)
NS 3 ml, 5 ml, 10 ml NS NS 3 ml, 5 ml, 10 ml syringe 7
Cabrero et al, 2005 [35] Cross-section study Hospital b IF and CF NS NS NS NS NS 6
Tseng et al, 2022 [6] Observation study Inpatients a (hypertonic, isotonic and hypotonic) osmolarity continuous intravenous drip VS IF NS NS NS NS NS 4, 5
Campbell et al., 2005 [36] Observation study Inpatients
(ambulatory patients)
a NS
(manual flushing)
NS NS q8h, q24h NS NS 4
Flint et al., 2008 [37] Observation study Inpatients a CF (10% dextrose) VS IF with 2 mL 0.9% sodium every 6 hours NS 2 ml q6h NS NS 5
Hoff et al., 2019 [38] Observation study Inpatients
(infants)
a CF: 0.2 mL/h
VS
IF: 5 mL before and 0.3 mL after the administration of intravenous medication
NS IF:5 mL before and 0.3 mL Before and after administration of intravenous medication NS NS 2, 4, 8
Stok et al., 2016 [39] Observation study Inpatients
(infants)
a Continuous infusion with 5% dextrose at 3 ml/h
VS
IF with 2 ml 0.9% saline six times daily
NS IF: 2 mL IF: q4h NS NS 2, 4, 8, 9
Ribeiro et al, 2023 [40] Observation study Nurses d continuous low-flow flushing and
PF
NS 5 mL and 10 ML NS NS NS 6
Nunes et al., 2022 [41] Observation study Nurses d PF NS Around
5 ML
Before, between, and after medication administration NS 10 ml 4
Lee et al., 2021 [42] Observation study Health professionals a NS NS NS NS NS Manually prepared syringe VS
pre-filled syringe
9, 10, 11, 12
Keogh et al., 2014 [43] Observation study Nurses e NS NS NS NS NS NS 6, 9, 10
Perez et al., 2012 [44] Observation study Inpatients
(infants)
a Continuous infusion (0.9% saline) VS IF (1 mL per day; if needed, antibiotics are flushed every 8h) Not specified for IF
CF: 2 ml/h
Continuous infusion: 2 ml/h;
IF:
1 ml per day
IF: 1 ml q24 or q8h NS 2
Wotton et al., 2004 [45] Observation study Nurses b IF NS 2-10 ml NS NS NS 6
Doyle et al., 2021 [46] Experimental study Lab study on
catheters
e Continuous infusion KVO infusion:10 mL/h, 20 mL/h, and 40 mL/h NS NS NS NS 2, 13, 14
Okamura et al, 2003 [47] Experimental study Lab study on
catheters
f PF VS CF CF: 10 mL/4, 7, or 10s
PF: 10 mL/4, 7, or 10s with 0.2,0.4, 0.8s pause with 1 ml inject
10 ml 1 time PF: 0.2,0.4, 0.8s NS 15
Zhu et al., 2020 [17] Experimental study Lab study on
catheters
e PF with varied bolus volumes 2.8, 6.8, 12.0, 18.5 mL/s. 0.5, 1, 1.5, and 2.0 mL Once 0.5 and 0.4 s NS 16, 17
Tong et al., 2019 [48] Experimental study Rabbit f PF, CF and control group PF: 5 successive boluses, 1 mL flushed in 0.5 s each.
CF: single 5 mL bolus (10 mL/min, flushing time is 30 s)
5 ml q8h PF:0.4s 5ml 1, 2, 18
Marques et al, 2019 [49] Experimental study Lab study on
catheters
f NS NS 10 ml NS NS NS 19
Ferroni et al, 2014 [50] Experimental study Lab study on
catheters
f PF VS CF PF: 1 ml/s
CF: 1 ml/s
10ml q24h NS NS 15
Guiffant et al, 2011 [51] Experimental study Lab study on
catheters
f PF, Continuous infusion, CF Varied CF: 10 ml
Continuous infusion: 500 ml
PF:10 ml
q24h Varied NS 19
Chittick et al., 2010 [52] Experimental study Lab study on
catheters
f PF PF: injecting 0.5 mL of saline 20 times over 10 seconds 10ml Once NS Syringe pump 15
Vigier et al., 2005 [15] Experimental study Lab study on
catheters
f steady flow vs. pulsed flow NS NS NS NS NS 16
Ribeiro et al, 2023 [53] mix-methods study Nurses b Varied Varied Varied Varied NS NS 6
Santos et al., 2022 [54] mix-methods study Inpatients and
Nurses
c NS NS Around
5 ML
Before, between, and after medication administration NS 10 ml 4
Norton et al., 2019 [55] mix-methods study Nurses c NS NS 2-10 mL, with 10 mL most frequent NS NS NS 6
Varalakshmi et al, 2018 [56] mix-methods study Inpatients a IF NS 2 ml q12h VS None NS NS 2
Cullinane et al., 2019 [14] guideline
Ribeiro et al, 2022 [57] review
Hawthorn et al., 2019 [19] review
Flint et al., 2005 [58] review
Fernandez et al, 2003 [59] review

Research Subject: A inpatients B Nurses; C Nurses and inpatients; D hospital; E Health professionals; F lab study on catheters; G Rabbit.

Research Settings: a Clinical environment; b Survey or questionnaires; c Mixed settings; d Observation in real clinical; e Simulation setting.

Research Design: Ⅰ intervention study; Ⅱ cross-sectional study; Ⅲ observational study; experimental study; mixed-methods study; guideline; ⅶ review.

Outcomes: 1 incidence of phlebitis; 2 Maintenance of catheter patency; 3 PIVC failure; 4 PIVC complications; 5 PIVC dwell time; 6 flushing practice evaluation (adherence to guideline practice); 7 incidence of catheter obstruction; 8 material cost; 9 time cost; 10 Risk of contamination; 11 Needlestick injuries; 12 Medication errors; 13 blood stasis; 14 shear stress on the vein; 15 bacterial growth/colonization; 16 flow characteristics; 17 mechanical behaviors;

18 histopathological changes; 19 protein removal efficiency/ albumin recovered.

Abbreviation: NS: Not specified; PF: Pulsatile flushing; IF: Intermittent flushing; CF: Continuous flushing; Versus: VS.

5.2. Research design

We categorized the research designs into several types: 4 review studies (integrative and narrative reviews) [19,5759], 6 intervention studies (including 5 randomized clinical trials) [26,27,2931,60], 4 cross-sectional studies (descriptive and survey-based) [3235], 11 observational studies (retrospective and prospective cohorts) [6,3645], 9 experimental studies (including quasi-experimental and simulation studies) [15,17,4652], 4 mixed-methods studies [5356], and 1 guideline [14].

5.3. Research subject and setting

The research subjects are categorized as follows: 11 studies focused on healthcare professionals, specifically nurses and midwives, as the professional discipline performing the flushing practice [3234,4043,45,5355]. 15 studies focused on hospitalized patients, including infants, newborns, and adults, assessing complications or outcomes associated with flushing [5,24,25,2729,3437,42,5456]. 2 studies investigated hospital-wide flushing practices at an institutional level [35,59]. 10 studies were conducted in simulated or laboratory environments to evaluate flushing techniques under controlled conditions [15,17,43,4649,51].

5.4. Flushing techniques

10 studies did not specify the flushing techniques, only vaguely described as manual flushing or flushing catheters [29,30,33,34,36,42,43,49,54,55]. 12 studies compared different flushing techniques, such as pulsatile flushing versus continuous flushing, or steady flow flushing versus pulsed flushing flow [6,15,26,27,3739,44,47,48,50,51]. One RCT study compared the effects of pulsatile flushing and continuous flushing. The result showed no statistical difference between pulsatile flushing and continuous flushing techniques regarding the time and type of PVC patency [27]. Other studies included intermittent flushing, continuous infusion, positive flush, and continuous and intermittent flushing combinations.

5.5. Flushing speed

The majority of the studies did not specify the flushing speed [6,15,26,2937,3943,45,49,5456,60]. One simulation study mentioned a steady flow rate of 4 cm³/s with a syringe pump [15]. Another study described two different flushing methods: one group received 5 successive boluses of 1 mL each, completed in 0.5 seconds, while the other group received a single 5 mL bolus at a rate of 10 mL/min, with a flushing time of 30 seconds [48]. Other studies mentioned varying flow rates, such as 2.8, 6.8, 12.0, and 18.5 mL/s, or indicated that the flushing speed was “faster than recommended” [17,27,47,50]. Some studies focused on continuous infusion, reporting varying infusion rates such as 0.2 mL/h, 3 mL/h, 10 mL/h, 20 mL/h, and 40 mL/h [38,44,46]. With only one interventional study on flushing speed [48], there is an opportunity to develop an RCT comparing clinical outcomes of different flushing speeds.

5.6. Flushing volume

The flushing volumes are varied. 9 studies did not specify the amount [6,15,26,28,35,36,42,43,46]. The most mentioned volumes are 10 mL and 5 mL, often used alone or in comparison with other amounts like 2 mL or 3 mL. Some studies provided a range, such as 2–10 mL [6,26,2835,38,39,44,46,47,54,55,59,60]. Two RCTs investigated the effect of flushing volume in combination with frequency [29,30]. Both compared low-volume (3 mL) versus high-volume (10 mL) flushing. The results showed no significant difference in PVC failure rates between the low- and high-volume groups. Overall, while 10 mL and 5 mL are common, there is variability and some lack specification.

5.7. Flushing frequency

We identified 13 studies that report scheduling of flushing is varied with no definite flushing frequency [5,13,24,26,32,33,38,40,41,43,44,47,53]. Further, 20 studies noted variability based on clinical circumstances and requirements, such as more frequent flushing during night shifts, after PVC insertion, before, between, and after drug delivery, or as needed [25,2731,34,37,39,42,45,46,4852,54]. Two RCTs also assessed flushing frequency, comparing low-frequency flushing (every 24 hours) with high-frequency flushing (every 6 hours). The findings indicated no significant reduction in PVC failure rates with more frequent flushing [29,30]. Common specific flushing frequencies were included in n = studies q24h(every 24 hours), q6h(every 6 hours), q8h(every 8 hours), and q12h(every 12 hours), often with medication administration [2931,36,39,44,47,48,5052,60]. Overall, the included studies have a mix of specific and variable frequencies.

5.8. Syringe used for flushing

The results regarding flushing syringe sizes, types, and prepared methods varied. A substantial portion (n = 20) of the included studies did not specify the syringe type, sizes, and prepared methods. Specific syringe sizes ranged from 2 ml to 10 ml and included 2 ml, 3 ml,5 ml, and 10 ml,. Certain studies highlighted brand-specific syringes, such as the BD Posi-Flush and BD PosiFlush XS syringes [27,43], and one study reported using a syringe pump [48].

5.9. Study outcome assessment for included studies

The included studies evaluated how various factors related to PIVC flushing influence catheter-related complications, describes as infection, infiltration, extravasation, occlusion, phlebitis, and thrombosis, as well as catheter failure. Several studies investigated the practitioner’s performing the catheter flushing in adherence to established guidelines (flushing frequency, volume, speed) [33,35,40]. A subset of studies also examined mechanical behaviors, flow characteristics of flushing techniques, and the impact of residual liquids on bacterial growth [47,50,61]. These outcome assessments collectively highlight the importance of safety, effectiveness, and protocol adherence in PIVC management.

6. Discussion

This scoping review aimed to comprehensively map the current state of PIVC flushing practices, focusing on the details of PIVC flushing process, revealing the diversity and complexity of research in this field. Our analysis included various geographical locations, study designs, study subjects, and flushing details, providing a broad perspective on PIVC flushing techniques and methods. The findings highlight both the progress made in understanding PIVC flushing and the challenges in establishing a standardized PIVC flushing practice. Using the PAGER framework,19 we discuss the main scoping review findings, which includes patterns, advances, gaps, evidence for practice, and research recommendations for PIVC flushing, as seen in Table 2.

Table 2. PAGER framework.

Pattern Advances Gaps Evidence for Practice Research Recommendations
Variation in PIVC flushing practice Research covers multiple regions Lack of multicenter studies representing diverse countries Current practices vary widely across hospitals, indicating a need for standardized protocols to ensure consistent patient care. Collaborative, multicenter studies are needed to explore effective flushing methods across different healthcare environments
The diversity in PIVC flushing techniques Explored different techniques like pulsatile, continuous, and intermittent flushing in clinical outcomes Lack of detailed and precise records of different flushing techniques, such as
Lack of detailed and precise records specifying whether push-pause or continuous flushing techniques were used.
Current guideline recommend flushing techniques, but there is no clear evidence on the most effective method. Conduct clinical trials to compare various techniques and conduct evidence-based practices
Physiological impact and safety of different flushing techniques Intervention studies have explored different flushing techniques and methods, analyzing their varying outcomes. There is no consensus on optimal volume and frequency, and many studies lack precise flushing methods and details Larger-scale intervention studies and flushing physiological impact basic experiments are needed to establish optimal practices. Further clinical trials and basic experiments from physiological safety aspect to identify the best combination of volume and frequency in varied settings
Lack of research on the mechanisms of PIVC flushing Some studies suggest that flushing methods (e.g., pulsatile) may prevent complications like infection and thrombosis Very few studies explore how different flushing techniques affect catheter patency or prevent complications such as damage to the endothelium. More clinical relevant research on the mechanisms of PIVC flushing is needed to bridge the gap between experimental findings and real-world practice. Future research should focus on understanding the underlying mechanisms of PIVC flushing to guide the development of evidence-based practices

6.1. Variation in PIVC flushing practice

The lack of a standardized protocol for PIVC flushing practices has led to significant variation across different regions and healthcare settings. Several factors, including differences in educational training, availability of medical resources, and staffing levels, influence this variation in practice [62]. Additionally, healthcare professionals may have a limited understanding of the importance of proper PIVC management, which can contribute to inconsistent practices [63,64]. Implementation studies are limited, with few studies exploring how research on PIVC flushing can be effectively translated into clinical workflows. One study evaluated errors in nursing teams’ flushing practices and developed a flushing prototype—a structured care guide to promote good flushing practices in intensive care units [53]. A single-center, stepped-wedge, cluster-randomized trial demonstrated the impact of a multifaceted intervention focused on PIVC maintenance [28]. The intervention, which included education on practice guidelines and the use of manufacturer-prepared pre-filled flush syringes, resulted in a significant reduction in PIVC failure rates—30% in the control group vs. 22% in the intervention group (risk difference −8%, 95% CI −14 to −1, p = 0.032). Importantly, the intervention also reduced total costs without any serious adverse events. These implementation studies emphasize the need to bridge the gap between research and practice, offering an opportunity for translational and implementation science to develop practical strategies that enhance guideline adherence.

6.2. The diversity in PIVC flushing techniques, speed, volume, frequency, and interval

One of the purposes for carrying out a scoping review is to identify the number of randomized controlled trials to justify the need for a full systematic review and meta-analysis [20]. In this scoping review, we included various clinical study designs, including RCT (n = 5), cohort studies (n = 4), and case-control study (n = 1). Three of the five RCT studies aimed to compare the high PIVC flushing volumes(3 ml or 10 ml) and frequencies(every 6 hours or every 24 hours) to evaluate the impact on catheter failure and complication rates [2931]. However, significant variability existed across these studies regarding flushing techniques, volumes, frequencies, patient populations, and other factors such as PIVC gauge and insertion site. This heterogeneity causes considerable confounding, limiting the ability to draw definitive conclusions about the optimal flushing strategies. Additionally, methodological differences—such as variations in patient populations (e.g., adult vs pediatric), treatment types (e.g., antibiotics or parenteral nutrition) definitions of outcomes (e.g., catheter failure rates vs dwell time). Given these limitations, conducting a systematic review with meta-analysis would be beneficial to quantitatively synthesize the available evidence and to clarify the relationship between specific flushing parameters and catheter outcomes. Additional rigorous clinical trials are essential to determine the optimal flushing techniques, volumes, and frequencies, particularly across different patient populations and clinical treatment types.

6.3. Physiological impact and safety of different flushing techniques

The included studies include several PIVC flushing techniques, including continuous flushing, intermittent flushing, and pulsatile flushing, representing current clinical flushing techniques. Continuous flushing provides a steady flow of solution with no interval, while intermittent flushing is used at set intervals to maintain catheter patency [1]. Pulsatile flushing, which involves short bursts of solution with pauses, is recommended to enhance debris clearance from the catheter [1,65]. However, current practice guidelines advocate using pulsatile flushing primarily based on experts’ opinions with limited evidence [12]. Ferroni et al. demonstrated that pulsatile flushing significantly reduced bacterial colonization, particularly for Staphylococcus aureus, compared to continuous flushing [50]. Boord et al. found that pulsatile flushing is better for maintaining catheter patency and clearing solid deposits from the catheter walls [12]. These findings support the theoretical benefits of pulsatile flushing; however, this evidence comes from in vitro studies, limiting the generalizability of the results to clinical practice. However, an included RCT study compared the effects of continuous flushing on PIVC and found no difference between continuous flushing and pulsatile flushing regarding the time and type of PIVC patency [27]. Another prospective study compared the duration of PIVC patency between continuous flushing and intermittent flushing and found that intermittent flushing resulted in a significantly longer cannula patency duration than continuous infusion (geometric mean 47.1 vs. 35.4 h, P = 0.041). The incidence of extravasation was higher with continuous infusion (68.9% vs. 43.2%; P = 0.001), while occlusion was more common with intermittent flushing (28.4% vs. 6.6%; P = 0.002) [44]. The pulsatile flushing shows theoretical benefits in laboratory settings, its clinical advantages remain uncertain. These mixed results suggest that the optimal flushing technique may vary depending on the clinical context and patient population. Further research is needed to establish standardized guidelines for these variations and ensure the best clinical outcomes.

6.4. Lack of research on the mechanisms of PIVC flushing

The understanding of the mechanisms behind PIVC flushing is limited, and few studies have explored fluid dynamics in the PIVC flushing process. Fluid dynamics in the context of PVC flushing refers to the study of fluid flow behavior and forces within the catheter during the flushing process. This includes how the flushing saline interacts with the catheter walls, generates turbulence and creates shear forces to remove the solid deposits in the internal catheter [17]. The studies by Vigier et al. and Ferroni et al. examined pulsatile flushing but used different methods [15,50]. Vigier et al., used a transparent rectangular duct (10 cm × 1.5 cm × 0.2 cm) connected to a pump to create controlled steady or unsteady flow. A thin layer of solid deposit was formed at the bottom by evaporating a mineral powder suspension in water, simulating catheter deposits. It took 70 seconds to initiate deposit removal under steady flow conditions (4 mL/s), whereas applying an intermittent flow, with the velocity doubling at 2-second intervals, reduced this time to 25 seconds. Ferroni et al., used polyurethane catheters contaminated with a controlled concentration of Staphylococcus aureus. Two flushing techniques controlled by a pump were compared: pulsative flushing (ten 1 mL boluses of saline) and continuous flushing (a single 10 mL bolus). Catheters flushed with the pulsative method had a significantly lower median bacterial count of 524 CFU/mL compared to 1,616 CFU/mL observed in catheters flushed with the continuous method, demonstrating the higher effectiveness of the pulsative technique in reducing bacterial contamination. However, the study by Zhu et al., investigated the mechanisms of pulsatile flushing using various bolus volumes and found that higher bolus volumes (1.5 mL and 2.0 mL) within 0.5 seconds, generating peak shear rates up to 10,000 s ⁻ ¹ can significantly increase the risk of mechanical endothelial injury [17]. The range for shear rates in vivo for the vein is 20–200 s−1 [65]. However, shear rates over 10,000 s−1 near the vessel wall induce platelet adhesion to thrombogenic surfaces [66,67]. Shear rates over 10,000 s ⁻ ¹ near the vessel wall induce platelet adhesion to thrombogenic surfaces. This process is mediated by the von Willebrand factor (vWF), which undergoes conformational changes under high shear, exposing binding sites that facilitate platelet aggregation. Elevated shear rates can also promote platelet activation and secretion of procoagulant substances, enhancing thrombus formation [68,69]. The experimental setup allowed for precise control over variables such as flow rate, bolus volume, and interval timing, allowing for accurate results regarding the effectiveness of flushing [40]. Educational materials/ clinical guidelines typically describe pulsatile flushing as a one-second flush followed by a one-second pause with no detailed description of flow rate, bolus volume, and interval timing [1]. Furthermore, there is a lack of detailed clinical data on actual flushing practices, making it difficult to determine whether the potential benefits of pulsatile flushing are superior to continuous infusion, such as keeping vein open approaches or manual flushing at a prescribed approach, outweigh the risks of endothelial injury. No meta-analysis has been conducted to evaluate the efficiency or efficacy of different flushing methods in clinical practice. Conducting a meta-analysis of existing studies is justified, as is the design of clinical simulation studies, conducting lab-based experiments measuring endothelia injury with flushing. Such approaches are essential to establishing robust evidence for PIVC flushing practices.

7. Conclusion

There are diverse and often inconsistent practices surrounding PIVC flushing. Various flushing techniques, such as continuous, intermittent, and pulsatile flushing techniques, with no consensus on the optimal volume, frequency, or technique to maintain PIVC patency and reduce PIVC complications. Despite the theoretical benefits of specific methods like pulsatile flushing, the evidence remains limited, and clinical data are rare. To address these challenges, further collaborative transdisciplinary research is needed to explore and understand the mechanism of flushing a PIVC in clinical practice.

Supporting information

S1 Table. Search terms and synonyms used for the literature search.

(DOCX)

pone.0330125.s001.docx (15.3KB, docx)
S2 Table. Data extraction form for included studies.

(DOCX)

pone.0330125.s002.docx (86.4KB, docx)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(1S Suppl 1):S1–224. doi: 10.1097/NAN.0000000000000396 [DOI] [PubMed] [Google Scholar]
  • 2.Cooke M, Ullman AJ, Ray-Barruel G, Wallis M, Corley A, Rickard CM. Not “just” an intravenous line: Consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries. PLoS One. 2018;13(2):e0193436. doi: 10.1371/journal.pone.0193436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, Berbel D, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality. J Hosp Infect. 2018;100(3):e178–86. doi: 10.1016/j.jhin.2018.06.010 [DOI] [PubMed] [Google Scholar]
  • 4.Corley A, Ullman AJ, Mihala G, Ray-Barruel G, Alexandrou E, Rickard CM. Peripheral intravenous catheter dressing and securement practice is associated with site complications and suboptimal dressing integrity: A secondary analysis of 40,637 catheters. Int J Nurs Stud. 2019;100:103409. doi: 10.1016/j.ijnurstu.2019.103409 [DOI] [PubMed] [Google Scholar]
  • 5.Frey AM, Schears GJ. Why are we stuck on tape and suture?: A review of catheter securement devices. Journal of Infusion Nursing. 2006;29. [DOI] [PubMed] [Google Scholar]
  • 6.Tseng J-H, Elaine Chen Y-F, Chang S-P, Wang H-C, Kuo Y-T. Factors affecting the patency and complications of peripheral intravenous catheters in newborns. Pediatr Neonatol. 2023;64(3):239–46. doi: 10.1016/j.pedneo.2022.07.011 [DOI] [PubMed] [Google Scholar]
  • 7.Marsh N, Larsen EN, Ullman AJ, Mihala G, Cooke M, Chopra V, et al. Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis. Int J Nurs Stud. 2024;151:104673. doi: 10.1016/j.ijnurstu.2023.104673 [DOI] [PubMed] [Google Scholar]
  • 8.Marsh N, Webster J, Larsen E, Cooke M, Mihala G, Rickard CM. Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: A Multivariable Analysis of Peripheral Intravenous Catheter Failure. Journal of Hospital Medicine. 2017;13(2):83–9. doi: 10.12788/jhm.2867 [DOI] [PubMed] [Google Scholar]
  • 9.Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but Unacceptable. Journal of Infusion Nursing. 2019;42(3):151–64. doi: 10.1097/nan.0000000000000326 [DOI] [PubMed] [Google Scholar]
  • 10.Maison O, Tardy C, Cabelguenne D, Parat S, Ducastelle S, Piriou V, et al. Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units. Eur J Clin Pharmacol. 2019;75(2):179–87. doi: 10.1007/s00228-018-2602-6 [DOI] [PubMed] [Google Scholar]
  • 11.Fan C-H, Chu C-N, Chiu F-H, Chen C-T, Tung H-H. Flushing and locking management related to central venous catheter occlusion rate among adult patients in acute care: a best practice implementation project. JBI Evid Implement. 2024;22(2):131–9. doi: 10.1097/XEB.0000000000000394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Boord C. Pulsatile Flushing: A Review of the Literature. J Infus Nurs. 2019;42(1):37–43. doi: 10.1097/NAN.0000000000000311 [DOI] [PubMed] [Google Scholar]
  • 13.Goossens GA. Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit. Nurs Res Pract. 2015;2015:985686. doi: 10.1155/2015/985686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cullinane C. Right Management and Flushing. In: Moureau NL, editor. Vessel Health and Preservation: The Right Approach for Vascular Access. Cham: Springer International Publishing; 2019. p. 243–261. doi: 10.1007/978-3-030-03149-7_19 [DOI] [Google Scholar]
  • 15.Vigier JP, Merckx J, Coquin JY, Flaud P, Guiffant G. The use of a hydrodynamic bench for experimental simulation of flushing venous catheters: impact on the technique. ITBM-RBM. 2005;26(2):147–9. doi: 10.1016/j.rbmret.2005.03.001 [DOI] [Google Scholar]
  • 16.Forauer AR, Theoharis C. Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol. 2003;14(9 Pt 1):1163–8. doi: 10.1097/01.rvi.0000086531.86489.4c [DOI] [PubMed] [Google Scholar]
  • 17.Zhu L, Liu H, Wang R, Yu Y, Zheng F, Yin J. Mechanism of pulsatile flushing technique for saline injection via a peripheral intravenous catheter. Clin Biomech (Bristol). 2020;80:105103. doi: 10.1016/j.clinbiomech.2020.105103 [DOI] [PubMed] [Google Scholar]
  • 18.Piper R, Carr PJ, Kelsey LJ, Bulmer AC, Keogh S, Doyle BJ. The mechanistic causes of peripheral intravenous catheter failure based on a parametric computational study. Sci Rep. 2018;8(1):3441. doi: 10.1038/s41598-018-21617-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hawthorn A, Bulmer AC, Mosawy S, Keogh S. Implications for maintaining vascular access device patency and performance: Application of science to practice. J Vasc Access. 2019;20(5):461–70. doi: 10.1177/1129729818820200 [DOI] [PubMed] [Google Scholar]
  • 20.Mak S, Thomas A. Steps for Conducting a Scoping Review. J Grad Med Educ. 2022;14(5):565–7. doi: 10.4300/JGME-D-22-00621.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Deng J, Hernon O, Liu L, Duggan C, Quinlan LR, Alfahl Z, et al. Mapping existing research on flushing peripheral vascular catheters: a scoping review protocol. BMJ Open. 2025;15(1):e088912. doi: 10.1136/bmjopen-2024-088912 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bradbury-Jones C, Aveyard H, Herber OR, Isham L, Taylor J, O’Malley L. Scoping reviews: the PAGER framework for improving the quality of reporting. International Journal of Social Research Methodology. 2021;25(4):457–70. doi: 10.1080/13645579.2021.1899596 [DOI] [Google Scholar]
  • 24.Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–26. doi: 10.11124/JBIES-20-00167 [DOI] [PubMed] [Google Scholar]
  • 25.Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6 PRISMA(7):e1000097. doi: 10.1371/journal.pmed.1000097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mali P, Chendake MB, Mohite VR. Efficacy of intermittent normal saline flushing of IV cannula to reduce the phlebitis. Journal of Pharmaceutical Negative Results. 2022:1597–606. doi: 10.47750/pnr.2022.13.S07.225 [DOI] [Google Scholar]
  • 27.Hosseini SJ, Eidy F, Kianmehr M, Firouzian AA, Hajiabadi F, Marhamati M, et al. Comparing the Effects of Pulsatile and Continuous Flushing on Time and Type of Peripheral Intravenous Catheters Patency: A Randomized Clinical Trial. J Caring Sci. 2021;10(2):84–8. doi: 10.34172/jcs.2021.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Keogh S, Shelverton C, Flynn J, Mihala G, Mathew S, Davies KM, et al. Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomised trial. BMC Med. 2020;18(1):252. doi: 10.1186/s12916-020-01728-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kleidon TM, Keogh S, Flynn J, Schults J, Mihala G, Rickard CM. Flushing of peripheral intravenous catheters: A pilot, factorial, randomised controlled trial of high versus low frequency and volume in paediatrics. J Paediatr Child Health. 2020;56(1):22–9. doi: 10.1111/jpc.14482 [DOI] [PubMed] [Google Scholar]
  • 30.Keogh S, Flynn J, Marsh N, Mihala G, Davies K, Rickard C. Varied flushing frequency and volume to prevent peripheral intravenous catheter failure: a pilot, factorial randomised controlled trial in adult medical-surgical hospital patients. Trials. 2016;17(1). doi: 10.1186/s13063-016-1470-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Schreiber S, Zanchi C, Ronfani L, Delise A, Corbelli A, Bortoluzzi R, et al. Normal saline flushes performed once daily maintain peripheral intravenous catheter patency: a randomised controlled trial. Arch Dis Child. 2015;100(7):700–3. doi: 10.1136/archdischild-2014-307478 [DOI] [PubMed] [Google Scholar]
  • 32.Parreira P, Vicente R, Bernardes RA, Sousa LB, Serambeque B, Costa P, et al. The flushing procedure in nursing practices: A cross-sectional study with Portuguese and Brazilian nurses. Heliyon. 2020;6(8):e04579. doi: 10.1016/j.heliyon.2020.e04579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Keogh S, Flynn J, Marsh N, Higgins N, Davies K, Rickard CM. Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey. Int J Nurs Stud. 2015;52(11):1678–85. doi: 10.1016/j.ijnurstu.2015.07.001 [DOI] [PubMed] [Google Scholar]
  • 34.Braga LM, Parreira PM dos SD, Arreguy-Sena C, Carlos DM, Mónico L dos SM, Henriques MAP. Taxa de incidência e o uso do flushing na prevenção das obstruções de cateter venoso periférico. Texto contexto - enferm. 2018;27(4). doi: 10.1590/0104-07072018002810017 [DOI] [Google Scholar]
  • 35.Cabrero J, Orts MI, López-Coig ML, Velasco ML, Richart M. Variability in the clinical practice of maintaining the patency of peripheral intravenous catheters. Gac Sanit. 2005;19(4):287–93. doi: 10.1157/13078026 [DOI] [PubMed] [Google Scholar]
  • 36.Campbell SG, Trojanowski J, Ackroyd-Stolarz SA. How often should peripheral intravenous catheters in ambulatory patients be flushed? J Infus Nurs. 2005;28(6):399–404. doi: 10.1097/00129804-200511000-00007 [DOI] [PubMed] [Google Scholar]
  • 37.Flint A, Davies M. The intravenous cannula for newborn infants requiring only intravenous medication: continuous infusion or intermittent flushing? J Infus Nurs. 2008;31(6):346–9. doi: 10.1097/NAN.0b013e31818c0d4a [DOI] [PubMed] [Google Scholar]
  • 38.Hoff R, Vervisch K, De Coen K, Smets K. Continuous infusion vs. intermittent flushing of peripheral cannulas in neonates using a needleless connector: a prospective cohort study. J Perinat Med. 2019;47(4):464–9. doi: 10.1515/jpm-2018-0285 [DOI] [PubMed] [Google Scholar]
  • 39.Stok D, Wieringa JW. Continuous infusion versus intermittent flushing: maintaining peripheral intravenous access in newborn infants. J Perinatol. 2016;36(10):870–3. doi: 10.1038/jp.2016.94 [DOI] [PubMed] [Google Scholar]
  • 40.Ribeiro G da SR, Campos JF, Camerini FG, Parreira PMSD, da Silva RC. Flushing in Intravenous Catheters. Journal of Infusion Nursing. 2023;46(5):272–80. doi: 10.1097/nan.0000000000000516 [DOI] [PubMed] [Google Scholar]
  • 41.Nunes de Almeida AC, Herculina Pires M, de Souza Santana I, de Oliveira Salgado P, Vieira Toledo L, Parreira P, et al. Effectiveness of an educational intervention for the prevention of peripheral venous catheter complications. Cogitare Enferm. 2022;(27):1–13. doi: 10.5380/ce.v27i0.87276 [DOI] [Google Scholar]
  • 42.Lee PT, Terry J. Changing practice to using pre-filled syringes for flushing IV cannulas. Br J Nurs. 2021;30(14):S14–22. doi: 10.12968/bjon.2021.30.14.S14 [DOI] [PubMed] [Google Scholar]
  • 43.Keogh S, Marsh N, Higgins N, Davies K, Rickard C. A time and motion study of peripheral venous catheter flushing practice using manually prepared and prefilled flush syringes. J Infus Nurs. 2014;37(2):96–101. doi: 10.1097/NAN.0000000000000024 [DOI] [PubMed] [Google Scholar]
  • 44.Perez A, Feuz I, Brotschi B, Bernet V. Intermittent flushing improves cannula patency compared to continuous infusion for peripherally inserted venous catheters in newborns: results from a prospective observational study. J Perinat Med. 2012;40(3):311–4. doi: 10.1515/jpm-2011-1000 [DOI] [PubMed] [Google Scholar]
  • 45.Wotton K, Gassner L-A, Ingham E. Flushing an i.v. line: a simple but potentially costly procedure for both patient and health unit. Contemp Nurse. 2004;17(3):264–73. doi: 10.5172/conu.17.3.264 [DOI] [PubMed] [Google Scholar]
  • 46.Doyle B, Kelsey L, Carr PJ, Bulmer A, Keogh S. Determining an Appropriate To-Keep-Vein-Open (TKVO) Infusion Rate for Peripheral Intravenous Catheter Usage. Journal of the Association for Vascular Access. 2021;26(2):13–20. doi: 10.2309/java-d-21-00006 [DOI] [Google Scholar]
  • 47.Okamura N, Yamaoka I. A comparison of the effects of pulsatile and bolus flushing methods on lipid emulsion residues that lead to bacterial growth in intravenous catheters. J Vasc Access. 2024;25(4):1320–7. doi: 10.1177/11297298231173162 [DOI] [PubMed] [Google Scholar]
  • 48.Tong C, Peng X, Hu H, Wang Z, Zhou H. The effect of different flushing methods in a short peripheral catheter. Acta Cir Bras. 2019;34(8). doi: 10.1590/s0102-865020190080000004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.CISBETI 2019 - International Congress of Health, Well-Being, Technology and Innovation. BMC Proc. 2019;13(S5). doi: 10.1186/s12919-019-0166-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ferroni A, Gaudin F, Guiffant G, Flaud P, Durussel J-J, Descamps P, et al. Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices. Med Devices (Auckl). 2014;7:379–83. doi: 10.2147/MDER.S71217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Guiffant G, Durussel JJ, Merckx J, Flaud P, Vigier JP, Mousset P. Flushing of Intravascular Access Devices (IVADs) - Efficacy of Pulsed and Continuous Infusions. J Vasc Access. 2011;13(1):75–8. doi: 10.5301/jva.2011.8487 [DOI] [PubMed] [Google Scholar]
  • 52.Chittick P, Sherertz RJ. Evaluation of the flush characteristics of 2 peripheral vascular catheters. Infect Control Hosp Epidemiol. 2010;31(12):1311–3. doi: 10.1086/657586 [DOI] [PubMed] [Google Scholar]
  • 53.Ribeiro GDSR, Campos JF, Parreira PMSD, Silva RCD. Care technology prototype for flushing practice in intravenous catheter maintenance. Texto contexto - enferm. 2023;32. doi: 10.1590/1980-265x-tce-2022-0302en [DOI] [Google Scholar]
  • 54.Santos-Costa P, Paiva-Santos F, Sousa LB, Bernardes RA, Ventura F, Fearnley WD, et al. Nurses’ Practices in the Peripheral Intravenous Catheterization of Adult Oncology Patients: A Mix-Method Study. J Pers Med. 2022;12(2):151. doi: 10.3390/jpm12020151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Norton CB, Alico Lauria H, Baker D, Hauser P, Smith-Miller CA. Nurses’ Short Peripheral Catheter Flushing Practices: Implications for Patient Care, Nursing Education, and Policy. J Infus Nurs. 2019;42(5):228–36. doi: 10.1097/NAN.0000000000000337 [DOI] [PubMed] [Google Scholar]
  • 56.Varalakshmi E, Usharani S. A Study to assess the effectiveness of Intermittent Flushing of Normal Saline to maintain A Patency of Intravenous Cannulation among Hospitalized patient in Saveetha Medical College and Hospital. Rese Jour of Pharm and Technol. 2018;11(10):4211. doi: 10.5958/0974-360x.2018.00771.0 [DOI] [Google Scholar]
  • 57.Ribeiro G da SR, Campos JF, Silva RC da. What do we know about flushing for intravenous catheter maintenance in hospitalized adults? Rev Bras Enferm. 2022;75(5):e20210418. doi: 10.1590/0034-7167-2021-0418 [DOI] [PubMed] [Google Scholar]
  • 58.Flint A, McIntosh D, Davies MW. Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug administration in newborn infants. Cochrane Database Syst Rev. 2005;(4):CD004593. doi: 10.1002/14651858.CD004593.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Fernandez RS, Griffiths RD, Murie P. Peripheral venous catheters: a review of current practices. J Infus Nurs. 2003;26(6):388–92. doi: 10.1097/00129804-200311000-00009 [DOI] [PubMed] [Google Scholar]
  • 60.Keogh S, Shelverton C, Flynn J, Mihala G, Mathew S, Davies KM, et al. Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomised trial. BMC Med. 2020;18(1):252. doi: 10.1186/s12916-020-01728-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.CISBETI 2019 - International Congress of Health, Well-Being, Technology and Innovation. BMC Proc. 2019;13(S5). doi: 10.1186/s12919-019-0166-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Alexandrou E, Ray-Barruel G, Carr PJ, Frost SA, Inwood S, Higgins N, et al. Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide. J Hosp Med. 2018;13(5):10.12788/jhm.3039. doi: 10.12788/jhm.3039 [DOI] [PubMed] [Google Scholar]
  • 63.Carr PJ, Glynn RW, Dineen B, Devitt D, Flaherty G, Kropmans TJB, et al. Interns’ attitudes to IV cannulation: a KAP study. Br J Nurs. 2011;20(4):S15-20. doi: 10.12968/bjon.2011.20.4.S15 [DOI] [PubMed] [Google Scholar]
  • 64.Sharma M, Paudel S, Shrestha U, Sitaula B. Knowledge of Intravenous Cannulation among Interns of a Teaching Hospital: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2022;60(247):290–3. doi: 10.31729/jnma.7222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Shi X, Yang J, Huang J, Long Z, Ruan Z, Xiao B, et al. Effects of different shear rates on the attachment and detachment of platelet thrombi. Mol Med Rep. 2016;13(3):2447–56. doi: 10.3892/mmr.2016.4825 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88(5):1525–41. doi: 10.1182/blood.v88.5.1525.1525 [DOI] [PubMed] [Google Scholar]
  • 67.Dunkley S, Harrison P. Platelet activation can occur by shear stress alone in the PFA-100 platelet analyser. Platelets. 2005;16(2):81–4. doi: 10.1080/09537100400010352 [DOI] [PubMed] [Google Scholar]
  • 68.Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26(8):1729–37. doi: 10.1161/01.ATV.0000229658.76797.30 [DOI] [PubMed] [Google Scholar]
  • 69.Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1(7):1335–42. doi: 10.1046/j.1538-7836.2003.00260.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Erik Su

9 Jun 2025

Dear Dr. Deng,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address the reviewers' comments as mentioned.

Please submit your revised manuscript by Jul 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Erik Su

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form, you indicated that your data will be submitted to a repository upon acceptance.  We strongly recommend all authors deposit their data before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire minimal  dataset will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. 

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Thank you all for your work. It is clear you spent a great deal of time and effort putting together a well thought out review.

I do not have any major revisions for you to complete only small adjustments below:

- In your introduction near line 110 it appears the first sentence of the new paragraph is a repeat of the description/ definition of pulsatile flushing that is mentioned up above. Nothing major it just reads as if you are defining it twice.

- For table 2- I did not see outcome 17 listed as being used in the table. Perhaps it was just not assigned to a paper or you could just remove it as an outcome.

- On section 5.5 on flushing speeds it may be worth considering converting the 4 cm3/sec to ml/sec to have consistency in the labeling of units throughout the manuscript. Again, near sentence at number line 478.

- For table 3 for the last row under the column Gaps- would reword the sentence to read “… patency or prevent complications or damage to the endothelium”. Essentially removing the word damage again at the end.

- Around line number 490- For the data on shear rates- I could not see where ref 67 Dunkley et. al states specific shear rates related to platelet aggregation. And I didn’t see mention of them by Ref 65 Nicholson. Perhaps the reference numbers got shifted a little.

Overall, this is a great review of the literature and a good summary of what is available to us.

Reviewer #2: Very interesting topic reviewed, especially the section on fluid dynamics.

Only point is the possible grammatical error of line 78 and PVC used without the explanation of what it stands for. Was this intended to be PIVC? PVC is later used and explained in line 251.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Aug 19;20(8):e0330125. doi: 10.1371/journal.pone.0330125.r002

Author response to Decision Letter 1


17 Jun 2025

Reviewer #1 comments & responses

Comment: In your introduction near line 110 it appears the first sentence of the new paragraph is a repeat of the description/ definition of pulsatile flushing that is mentioned up above.

Response: Thanks for your comment. We have revised the sentence in Line 128.

Comment: For table 2 - I did not see outcome 17 listed as being used in the table. Perhaps it was just not assigned to a paper or you could just remove it as an outcome.

Response: Thank you for your comment. Outcome 17 was indeed used in Table 2 and assigned to the study by Zhu et al. (2020) on Page 19.

Comment: On section 5.5 on flushing speeds it may be worth considering converting the 4 cm³/sec to ml/sec to have consistency in the labeling of units throughout the manuscript.

Response: Thank you for your comment. We have revised the unit from “4cm³” to “4mL/s” in section 5.5 and Line 514.

Comment: For table 3, for the last row under the column Gaps — would reword the sentence to read “… patency or prevent complications or damage to the endothelium”. Essentially removing the word damage again at the end.

Response: Thank you for your comment. We have revised the sentence as seen in Table 3.

Comment: Around line number 490 — For the data on shear rates — I could not see where ref 67 Dunkley et al. states specific shear rates related to platelet aggregation. And I didn’t see mention of them by Ref 65 Nicholson. Perhaps the reference numbers got shifted a little.

Response: Thank you for your helpful comment. We have reviewed the references and identified that the original References 65 and 67 did not adequately support the statements regarding physiological and pathological shear rates and their impact on platelet aggregation. We have replaced Reference 65 with Shi et al. (2015), which provides a detailed explanation of shear rate ranges in vein. Reference 67 has been updated to Casa et al. (2016), which reports on the effects of different shear rates on platelet thrombi formation and detachment. Both references have been appropriately cited in the revised text, as seen in Line 791 and Line 796.

Reviewer #2 comments & responses

Comment: Only point is the possible grammatical error of line 78 and PVC used without the explanation of what it stands for. Was this intended to be PIVC? PVC is later used and explained in line 251.

Response: Thanks for your comment. It was a typo in Line 78 — should have been PIVC (peripheral intravenous catheter). We have corrected this in Line 96.

Attachment

Submitted filename: Response to Reviewers plos one.docx

pone.0330125.s004.docx (15.6KB, docx)

Decision Letter 1

Erik Su

27 Jul 2025

Flushing Peripheral Intravenous Catheters: A Scoping Review

PONE-D-25-22430R1

Dear Dr. Deng,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Erik Su

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: No additional comments. Thank you for your updates.

Reviewer #2: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Mark D. Weber MSN, RN, CRNP-AC, FCCM

Reviewer #2: No

**********

Acceptance letter

Erik Su

PONE-D-25-22430R1

PLOS ONE

Dear Dr. Deng,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Erik Su

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Search terms and synonyms used for the literature search.

    (DOCX)

    pone.0330125.s001.docx (15.3KB, docx)
    S2 Table. Data extraction form for included studies.

    (DOCX)

    pone.0330125.s002.docx (86.4KB, docx)
    Attachment

    Submitted filename: Response to Reviewers plos one.docx

    pone.0330125.s004.docx (15.6KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES